Methadone is a synthetic opioid analgesic used primarily in the treatment of opioid use disorder (OUD) and for the management of chronic pain. Due to its chemical structure and specific metabolic pathway, detection requires specific testing methodologies. Standard drug screening panels often do not include assays that identify this particular substance.
The necessity of identifying methadone stems from its controlled use and potential for diversion. Monitoring adherence to prescribed methadone treatment plans is crucial for ensuring patient safety and preventing misuse. Furthermore, detecting the presence of methadone can be important in forensic toxicology and workplace drug testing scenarios where opioid use is restricted.